Filing Details
- Accession Number:
- 0001628280-25-010973
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-06 16:56:39
- Reporting Period:
- 2025-03-04
- Filing Date:
- 2025-03-06
- Accepted Time:
- 2025-03-06 16:56:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1995298 | A. Sheila Denton | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-03-04 | 599 | $58.06 | 26,447 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-03-04 | 599 | $69.99 | 25,848 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2025-03-04 | 599 | $0.00 | 599 | $58.06 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
18,552 | 2033-10-02 | No | 4 | M | Direct |
Footnotes
- This includes an aggregate of 25,848 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.
- Beginning October 2, 2023, options become exercisable in 37 installments, with the first 25% vesting on October 2, 2024 and the remainder vesting monthly over three years.